Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

OSR Health, Inc. - Common Stock (NQ:OSRH)

0.2800 -0.0149 (-5.05%)
Streaming Delayed Price Updated: 12:59 PM EDT, Aug 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about OSR Health, Inc. - Common Stock

< Previous 1 2 Next >
News headline image
OSR Health: Preparing Our Appeal, Advancing Our Catalysts, Continuing Our Mission
From OSR Health, Inc.
Via ACCESS Newswire
News headline image
OSR Health Receives Nasdaq Staff Delisting Determination and Intends to Request Hearings Panel Appeal
From OSR Health, Inc.
Via ACCESS Newswire
News headline image
OSR Health Sees Global Shareholder Momentum at Critical Inflection Point
From OSR Health, Inc.
Via ACCESS Newswire
News headline image
VivoSim Labs (NASDAQ: VIVS) Among IGC, OSRH, IVF as FDA-Backed Human-Based Testing Gains Momentum
Via AB Newswire
Topics Animal Testing Artificial Intelligence
News headline image
OSR Health CEO Reaffirms Confidence and Highlights Subsidiary Business Development
From OSR Health, Inc.
Via ACCESS Newswire
News headline image
CEO Statement to Shareholders
Via ACCESS Newswire
News headline image
CEO Statement to Shareholders
Via ACCESS Newswire
News headline image
OSR Health Issues Clarification Regarding Prior Nasdaq Communication and Shareholder Loyalty CVR Program
From OSR Health, Inc.
Via ACCESS Newswire
News headline image
Vaximm AG, an OSR Company, Announces Forthcoming Publication of Cross-Indication Clinical Data for VXM01, Its VEGFR-2-Targeted Cancer Vaccine Platform
From OSR Health, Inc.
Via ACCESS Newswire
News headline image
OSR Health Secures Nasdaq Communication: Loyalty CVR Program Will Not Trigger a Price Adjustment
From OSR Health, Inc.
Via ACCESS Newswire
News headline image
OSR Health, A Message From the CEO
From OSR Health, Inc.
Via ACCESS Newswire
News headline image
CORRECTION FROM SOURCE: Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target
From OSR Health, Inc.
Via ACCESS Newswire
News headline image
Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target
From OSR Health, Inc.
Via ACCESS Newswire
News headline image
OSR Health Announces Shareholder Loyalty Program to Reward Conviction Holders With Additional Shares
From OSR Health, Inc.
Via ACCESS Newswire
News headline image
OSR Holdings Is Now OSR Health - A New Name That Says Exactly What We Do
From OSR Health, Inc.
Via ACCESS Newswire
News headline image
OSR Holdings Acquires Full VXM01 Intellectual Property Portfolio in $30 Million Transaction
Via ACCESS Newswire
News headline image
Emerging Growth Research Issues Flash Report on OSR Holdings, Reaffirms Buy-Emerging Rating and $10.00 Price Target
Via ACCESS Newswire
News headline image
OSR Holdings to Present VXM01 Licensing Agreement at Emerging Growth Conference May 7, 2026
Via ACCESS Newswire
News headline image
OSR Holdings Executes Definitive $815 Million Global License Agreement for VXM01 with BCM Europe
Via ACCESS Newswire
News headline image
OSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible Note
Via ACCESS Newswire
News headline image
OSR Holdings to Update Investors at the Emerging Growth Conference on April 1, 2026
Via ACCESS Newswire
News headline image
Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target
Via ACCESS Newswire
News headline image
OSR Holdings Updates $815 Million VXM01 Licensing Deal Structure to Capture Value at Parent Level
Via ACCESS Newswire
News headline image
Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities
Via ACCESS Newswire
News headline image
OSR Holdings, Inc. Granted 180-Day Nasdaq Extension; Reaffirms Strategic Momentum
Via ACCESS Newswire
News headline image
CEO Statement to Shareholders
Via ACCESS Newswire
News headline image
Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target Following Major Licensing Agreement
New York, New York--(Newsfile Corp. - December 4, 2025) - Emerging Growth Research today issued a flash report on OSR... 
Via Newsfile
News headline image
Kartoon Studios Mainframe Studios, Toon Media, and Premium IP Pipeline Drive 2026-2027 Outlook
Via AB Newswire
News headline image
Emerging Growth Research Initiates Coverage on OSR Holdings, Inc. with a Buy-Emerging Rating and $10.00 Price Target
New York, New York--(Newsfile Corp. - October 20, 2025) - Emerging Growth Research today announced the initiation of coverage on... 
Via Newsfile
News headline image
$2 Stocks to Watch: PNPN.V, TIVC, APVO, OSRH, PRSO Biotech Breakthroughs, MedTech Momentum Metallic Metals Power Play & Signal Innovation
Via AB Newswire
Topics Intellectual Property
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.